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abstract
 
Airway epithelia are confronted with distinct signals emanating from the luminal and/or serosal en-
 
vironments. This study tested whether airway epithelia exhibit polarized intracellular free calcium (Ca
 
2
 
1
 
i
 
) and an-
ion secretory responses to 5
 
9
 
 triphosphate nucleotides (ATP/UTP), which may be released across both barriers of
these epithelia. In both normal and cystic ﬁbrosis (CF) airway epithelia, mucosal exposure to ATP/UTP increased
Ca
 
2
 
1
 
i
 
 and anion secretion, but both responses were greater in magnitude for CF epithelia. In CF epithelia, the mu-
cosal nucleotide–induced response was mediated exclusively via Ca
 
2
 
1
 
i
 
 interacting with a Ca
 
2
 
1
 
-activated Cl
 
2
 
 chan-
nel (CaCC). In normal airway epithelia (but not CF), nucleotides stimulated a component of anion secretion via a
chelerythrine-sensitive, Ca
 
2
 
1
 
-independent PKC activation of cystic ﬁbrosis transmembrane conductance regulator.
In normal and CF airway epithelia, serosally applied ATP or UTP were equally effective in mobilizing Ca
 
2
 
1
 
i
 
. How-
ever, serosally applied nucleotides failed to induce anion transport in CF epithelia, whereas a PKC-regulated anion
secretory response was detected in normal airway epithelia. We conclude that (1) in normal nasal epithelium, api-
cal/basolateral purinergic receptor activation by ATP/UTP regulates separate Ca
 
2
 
1
 
-sensitive and Ca
 
2
 
1
 
-insensitive
(PKC-mediated) anion conductances; (2) in CF airway epithelia, the mucosal ATP/UTP-dependent anion secre-
tory response is mediated exclusively via Ca
 
2
 
1
 
i
 
; and (3) Ca
 
2
 
1
 
i
 
 regulation of the Ca
 
2
 
1
 
-sensitive anion conductance
(via CaCC) is compartmentalized in both CF and normal airway epithelia, with basolaterally released Ca
 
2
 
1
 
i
 
 failing
to activate CaCC in both epithelia.
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INTRODUCTION
 
The pathogenesis of cystic ﬁbrosis (CF)
 
1
 
 lung disease is
complex, but likely involves abnormal regulation of the
airway surface liquid. Airway surface liquid volume reg-
ulation reﬂects the integrated function of cystic ﬁbrosis
transmembrane conductance regulator (CFTR) as a Cl
 
2
 
channel and as a regulator of the epithelial Na
 
1
 
 chan-
nel. Further, there is compelling evidence that a second,
calcium-activated Cl
 
2
 
 channel (CaCC) pathway exists in
the apical membrane of airway epithelia (Al-Bazzaz and
Jayaram, 1981; Barthelson et al., 1987; Welsh, 1987;
Boucher et al., 1989; Willumsen and Boucher, 1989;
Hartmann et al., 1992), which is regulated by increases
in intracellular free Ca
 
2
 
1
 
 (Ca
 
2
 
1
 
i
 
). In the airway of the
 
CFTR(
 
2
 
/
 
2
 
) knockout mouse (Snouwaert et al., 1992),
the CaCC pathway is preserved, and, in some regions,
upregulated (Grubb and Boucher, 1999). Similarly, in
human CF airway epithelia, this Ca
 
2
 
1
 
i
 
-regulated Cl
 
2
 
 con-
ductance may also be upregulated, as initially revealed
by studies with Ca
 
2
 
1
 
 ionophores (Boucher et al., 1989;
Willumsen and Boucher, 1989).
Extracellular triphosphate nucleotides are released in
response to local stresses in the airways and may exert
autocrine/paracrine effects on ion transport (Leuba et
al., 1996; Taylor et al., 1998; Homolya et al., 2000).
Triphosphate nucleotides have been reported to stimu-
late Cl
 
2
 
 secretion through non-CFTR, CaCC-dependent
mechanisms (Mason et al., 1991), both in normal and
CF airway epithelia (Knowles et al., 1991; Clarke and
Boucher, 1992). External ATP and UTP mediate their
effects in airway epithelia, at least in part, via interac-
tions with the P2Y
 
2
 
 purinergic receptor (P2Y
 
2
 
-R; Parr et
al., 1994). In human airway epithelia, P2Y
 
2
 
-R is linked
 
to PLC-generated inositol(1,4,5) trisphosphate (IP
 
3
 
)–
mediated release of Ca
 
2
 
1
 
i
 
 (Brown et al., 1991). How-
ever, the transduction pathways that link occupancy of
airway P2Y
 
2
 
-Rs to Cl
 
2
 
 secretion are complex, and previ-
ous reports raise questions with respect to differences in
the polarity of nucleotide responses in normal airway
epithelia and differences in the pattern of nucleotide
responses exhibited by normal and CF airway epithelia
(Mason et al., 1991; Clarke and Boucher, 1992). The
following three examples, juxtaposing independent ob-
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Abbreviations used in this paper:
 
 CaCC, Ca
 
2
 
1
 
-activated Cl
 
2
 
 channel;
CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance
regulator; Ca
 
2
 
1
 
i
 
, intracellular free Ca
 
2
 
1
 
; DAG, diacylglycerol; IP
 
3
 
,
inositol 1,4,5-trisphosphate; P2Y
 
2
 
-R, P2Y
 
2
 
 purinergic receptor. 
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Simultaneous Measurements of Ca
 
2
 
1
 
i
 
 and Cl
 
2
 
 Transport
 
servations from electrophysiologic (Cl
 
2
 
 secretion) and
imaging studies (
 
D
 
Ca
 
2
 
1
 
i
 
), illustrate these questions.
First, whereas activation of apical P2Y
 
2
 
-Rs by nucle-
otides evoked smaller changes in Ca
 
2
 
1
 
i
 
 than basolateral
P2Y
 
2
 
-R activation (Paradiso et al., 1995), experiments
by Clarke and Boucher (1992) showed that the rela-
tionship for Cl
 
2
 
 secretion was inverse, i.e., the magni-
tude of the Cl
 
2
 
 secretory response was greater after api-
cal than after basolateral additions of extracellular nu-
cleotides. These studies raised the issue of whether the
membrane location (apical/basolateral) of nucleotide-
induced Ca
 
2
 
1
 
 release, and hence local Ca
 
2
 
1
 
i
 
 concentra-
tion, are important for Cl
 
2
 
 secretion in airway epithe-
lia. Second, in cultured normal airway epithelial cells
prestimulated with ionomycin to maximally raise Ca
 
2
 
1
 
i
 
activity, treatment with the endoplasmic reticulum
Ca
 
2
 
1
 
-ATPase inhibitor thapsigargin evoked no addi-
tional Cl
 
2
 
 secretion, whereas luminal ATP activated an
additional Cl
 
2
 
 secretory response without a further rise
in Ca
 
2
 
1
 
i
 
 (Stutts et al., 1994). This ﬁnding suggested the
possibility that extracellular nucleotides regulate Cl
 
2
 
secretion via Ca
 
2
 
1
 
-independent pathways (e.g., PKC)
and, perhaps, via a different Cl
 
2
 
 channel (e.g., CFTR).
Third, in normal human airways, basolateral applica-
tion of ATP induced a Cl
 
2
 
 secretory response, whereas
this response could not be detected in CF (Clarke and
Boucher, 1992) despite similar changes in Ca
 
2
 
1
 
i
 
 (Ma-
son et al., 1991), raising the possibility of compartmen-
talization of Ca
 
2
 
1
 
i
 
 signaling in columnar airway epithe-
lial cells (Paradiso, 1997).
In the present study, we sought to test the relative
roles of polarized Ca
 
2
 
1
 
i
 
 mobilization and PKC activa-
tion in response to mucosal versus serosal nucleotide
administration in normal and CF airway epithelia. We
speciﬁcally explored the hypotheses that (1) in normal
airway epithelia, luminal addition of nucleotides acti-
vates both CaCC and CFTR, whereas basolateral addi-
tion activates only CFTR; (2) in CF airway epithelia,
apical P2Y
 
2
 
-R activation is effective in activating only
CaCC; and (3) Ca
 
2
 
1
 
i
 
 signals evoked by serosal nucle-
otides in both normal and CF are functionally conﬁned
to the basolateral domain. For these experiments, we
developed the necessary measurement systems that per-
mitted simultaneous measurements of Ca
 
2
 
1
 
i
 
 and anion
secretion.
 
MATERIALS AND METHODS
 
Tissue Samples
 
Nasal epithelial cells were obtained from 10 normal subjects
(34
 
 6 
 
7 yr old [four males and six females]) undergoing elective
surgery for standard medical indications (e.g., sleep apnea sec-
ondary to nasal obstruction), and eight CF patients (16
 
 6 
 
5 yr
old [four males and four females]). All procedures were ap-
proved by the University of North Carolina Committee for the
Rights of Human Subjects.
 
Chemicals and Solutions
 
Acetoxymethyl ester (AM) of Fura-2, 4,4
 
9
 
 diisothiocyanatodihy-
drostilbene-2,2
 
9
 
-disulfonic acid (H
 
2
 
DIDS), and BAPTA were pur-
chased from Molecular Probes. Chelerythrine chloride and PMA
were purchased from Alexis Biochemical. ATP and UTP were ob-
tained from Boehringer Mannheim Biochemical. Ionomycin and
thapsigargin were obtained from Calbiochem-Novabiochem. All
other chemicals were obtained from Sigma-Aldrich.
Stock solutions of Fura-2/AM, BAPTA-AM, ionomycin, PMA,
chelerythrine, and thapsigargin, all at 1 mM, were dissolved in
DMSO and stored up to 30 d at 
 
2
 
20
 
8
 
C without a loss of potency
of the drugs. Stock solutions of 
 
N
 
-methyl-
 
d
 
-glucamine (NMG)
gluconate and NMG-Cl (both at 0.5 M, pH 7.0) were prepared by
mixing NMG base with equimolar concentrations of 
 
d
 
-gluconic
acid lactone and HCl, respectively, and stored up to 1 wk at 4
 
8
 
C.
For Na
 
1
 
-free, HCO
 
3
 
2
 
-containing solutions, a stock solution of
NMG-HCO
 
3
 
 (1 M, pH 7.0) was prepared by bubbling NMG base
(1 M) with 100% CO
 
2
 
.
The standard Kreb’s bicarbonate Ringer (KBR) solution con-
tained (in mM): 125 NaCl, 2.5 K
 
2
 
HPO
 
4
 
, 1.3 CaCl
 
2
 
, 1.3 MgCl
 
2
 
, 25
NaHCO
 
3
 
, and 5 
 
d
 
-glucose (5% CO
 
2
 
/95% O
 
2
 
). For NMG-Cl
Ringer solution, NaCl and NaHCO
 
3
 
 were replaced mole for mole
by NMG-Cl and NMG-HCO
 
3
 
, respectively. For NMG-gluconate
(low Cl
 
2
 
) Ringer, NaCl and NaHCO
 
3
 
 were replaced mole for
mole with NMG-gluconate and NMG-HCO
 
3
-
 
, respectively (ﬁnal
Cl
 
2
 
 
 
5 
 
2.6 mM) and 2 mM CaSO
 
4
 
 was added to the solution to
compensate for Ca
 
2
 
1
 
 chelation by gluconate, as previously re-
ported (Clarke and Boucher, 1992).
 
Cell Culture, Perfusion Chamber, and
Bioelectric Measurements
 
Nasal epithelial cells were harvested from polyps by enzymatic di-
gestion (Protease XIV [Sigma-Aldrich] for 24-48 h at 4
 
8
 
C] as pre-
viously described (Wu et al., 1985). Nasal epithelial cells were
plated on porous Transwell Col ﬁlters (pore diam 
 
5
 
 0.4 
 
m
 
m; Cos-
tar) afﬁxed to O-rings and maintained in serum-free Ham’s F12
medium supplemented with insulin (10 
 
m
 
g/ml), transferrin (5
 
m
 
g/ml), 3,3
 
9
 
,5-triiodothyronine (3 
 
3
 
 10
 
2
 
8 M), endothelial cell
growth supplement (3.75 mg/ml), hydrocortisone (5 3 1029 M),
and CaCl2 (1023 M). Polarized monolayers were studied 7–12 d
after seeding, a time coincident for the development of the max-
imal transepithelial potential difference (Vt). For normal nasal
epithelium Vt 5 29.8 6 1.2 mV mucosal side negative and chord
resistance (RT) 5 408 6 32 V?cm2 (n 5 90; 10 different individu-
als); for CF Vt 5 221.7 6 1.4 mV, and RT 5 396 6 38 V?cm2 (n 5
85; 8 different individuals).
After conﬂuency was achieved, polarized monolayers of nor-
mal or CF epithelium were loaded with Fura-2 (5 mM at 378C for
25 min) or coloaded with 100 mM BAPTA-AM 6 1 mM cheleryth-
rine chloride before being mounted in a miniature Ussing cham-
ber over an objective (Zeiss LD Achroplan 403, NA 0.6; working
distance 1.8 mm) of a Zeiss Axiovert 35 microscope. The cham-
ber is similar in design to that described by Larsen et al. (1990)
for sweat duct epithelial cells in primary culture. In brief, a per-
fusion chamber was constructed in which solutions bathing api-
cal and basolateral surfaces could be changed rapidly and inde-
pendently. The chamber consists of top (mucosal) and bottom
(serosal) half-chambers (volume 5 250 ml each) made from
light-absorbing polyacetal. The Transwell wafer containing the
cell monolayer was mounted apical surface up, between the two
half-chambers. Effective sealing is achieved by means of rubber
O-rings embedded in grooves of the two half-chambers, which
are screwed tightly together. A glass coverslip is afﬁxed to the bot-
tom of the serosal chamber with dental sticking wax (model
Deiberit-502; Ludwig Bohme). The mucosal chamber is open to55 Paradiso et al.
the atmosphere. Both half-chambers have inlet and outlet ports
for solution ﬂow. When mounted and tightly sealed, the mono-
layer is z1.5 mm from the glass coverslip. For passing current,
two circular Ag/AgCl electrodes are placed in the two half-cham-
bers to secure a uniform density of current through the prepara-
tion. For measurements of the Vt, polyethylene bridges contain-
ing 2 M KCl in 2% agar are positioned in the two half-chambers
and connected to calomel electrodes (Radiometer).
The chamber system also has a perfusion incubator with eight
mucosal and eight serosal reservoirs containing Ringer solution,
which are uniformly prewarmed to z428C with a small heater and
fan. The prewarmed Ringer solutions are delivered to the cham-
ber by gravity ﬂow (rate 5 3–5 ml/min) through tubing that is
kept as short as possible (z20 cm) to minimize heat loss. Serosal
and mucosal solutions are changed by using two eight-port valves
(Hamilton). The half-time for solution exchange is ,3 s.
For bioelectric measurements, Vt was monitored by a voltage
clamp/pulse generator (model VCC600; Physiologic Instru-
ments) and the signal was recorded on a two-channel recorder
(model L2005; Linseis). All experiments were performed under
open circuit conditions. To calculate the equivalent current from
changes in Vt in response to purinergic receptor activation, a de-
ﬁned (1 or 2 mA) 1-s current pulse was delivered across the tissue
every 5 s (see Fig. 1), and from the magnitude change in the de-
ﬂection of Vt, the chord resistances, and subsequent equivalent
currents, were calculated using Ohm’s law. To convert the tissue
from its native Na1 absorptive state and increase the transepithe-
lial Cl2 driving force, nasal monolayers were exposed to Na1-
free/low Cl2 Ringer in the mucosal bath with KBR remaining
constant in the serosal perfusate.
Fluorimeter and Measurements of Ca21
i
Measurements of Ca21
i in monolayers were obtained using a Ra-
dioMaster ﬂuorimeter (Photon Technology International) cou-
pled via ﬁber optics to the microscope. Fura-2 ﬂuorescence from
30–40 cells (spot diameter z65 mm) was acquired alternately at
340 and 380 nm (emission . 450 nm). Excitation slit widths were
minimized to reduce photodamage to cells and bleaching of the
dye. At a given excitation wavelength (340 or 380 nm), back-
ground light levels were measured by exposing cells to digitonin
(15 mM) and MnCl2 (1023 M) and subtracted from the corre-
sponding signal measured in Fura-2–loaded cells before taking
the ratio (340/380). The corrected ratio was converted to Ca21
i
by using external Ca21 standards as described previously (Para-
diso et al., 1995).
Data Analysis
Where applicable, data are presented as the mean 6 SEM for a
given experimental condition. All of the data presented in sum-
mary form are expressed as the absolute change (D) in Ca21
i and
anion secretion (peak basal values) before and after the addition
of ATP/UTP to monolayers. Negative equivalent currents refer
to the luminal side of the monolayer, negative with respect to the
serosal side (Clarke and Boucher, 1992). The mean effective
dose (ED50) was calculated from the Boltzman model (Willard et
al., 1974). Statistical signiﬁcance was determined using the t test,
with P , 0.05 being considered signiﬁcant.
RESULTS
Simultaneous Measurements of Cell Ca21 and Anion 
Transport in Nasal Monolayers
To compare the effects of apical versus basolateral
triphosphate nucleotides on changes in Ca21
i and an-
ion secretion, we chose experimental conditions that
maximized the signal generated by anion movement
through the apical membrane by bathing the prepara-
tions with Na1-free, low Cl2 Ringer. Representative
tracings depicting simultaneous measurements of an-
ion secretion and changes in Ca21
i induced by serosal
or mucosal administration of ATP (100 mM) in normal
and CF epithelial cell preparations are shown in Fig. 1
(A and B). The downward deﬂections shown in each
tracing (Fig. 1, A and B) were produced by passing a
current pulse across the tissue as described in materi-
als and methods, and the break in the tracings repre-
sents a 30-min washout period after serosal ATP treat-
ment before exposing monolayers to mucosal ATP.
Under these conditions, there exist chemical gradi-
ents across the intercellular shunt for Na1 and Cl2.
These gradients generate electromotive forces that con-
tribute to basal Vt, but previous equivalent circuit analy-
Figure 1. Simultaneous measurements of intracellular Ca21
(Ca21
i) and transepithelial potential difference (Vt) in normal (A)
and cystic ﬁbrosis (CF; B) nasal epithelia. Monolayers of nasal epi-
thelial cells were initially perfused bilaterally in Kreb’s bicarbonate
Ringer before changing to mucosal Na1-free (N-methyl-d-gluca-
mine [NMG]) Cl2), and then Na1-free/low Cl2 (2.6 mM; NMG
gluconate) Ringer. 100 mM ATP was added to the serosal (S) or
mucosal (M) bath as indicated. The break in the traces represents
a washout period (z30 min) for serosal ATP before adding mu-
cosal ATP to the perfusate. At 100 mM ATP, each trace is represen-
tative of at least 85 independent experiments (eight or more dif-
ferent individuals).56 Simultaneous Measurements of Ca21
i and Cl2 Transport
ses have shown that ATP (Clarke and Boucher, 1992) or
ionomycin (Willumsen and Boucher, 1989) elicited
no signiﬁcant changes in shunt resistance. Thus, the
change from basal Vt evoked by triphosphate nucle-
otides likely reﬂects changes in the electrical diffusion
potential dominated by transcellular Cl2 secretion as
previously reported (Lazarowski et al., 1997). However,
we cannot rule out other anions secreted during puri-
nergic receptor activation in human airway epithelia.
For example, HCO3
2 has been implicated as a relevant
anion during transepithelial ion transport (Illek et al.,
1997; Clarke and Harline, 1998). Moreover, CFTR has a
Figure 2. Dose–response
relationship for the effects of
ATP on the change in anion
secretion and intracellular
Ca21 (Ca21
i) in normal and
cystic ﬁbrosis (CF) nasal epi-
thelia. In monolayers per-
fused in serosal Kreb’s bicar-
bonate Ringer and luminal
Na1-free/low Cl2 Ringer,
ATP (1029–1024 M) was
added to either mucosal (A)
or serosal (B) bathing solu-
tion. The change in anion
transport and Ca21
i was calcu-
lated as the absolute differ-
ence between maximal ATP-
stimulated anion transport
and Ca21
i and steady-state
equivalent current and Ca21
i
before ATP addition. Each
data point represents mean 6
SEM for at least six indepen-
dent experiments (six or
more different individuals).
Normal and CF values are sig-
niﬁcantly different (*P , 0.05
and **P , 0.01) from each
other. For basolateral changes
in Ca21
i, values were not signiﬁcantly different (P . 0.05; symbol not shown) between the normal and CF epithelia. For normal airway, the
change in anion secretion and Ca21
i in response to apically applied ATP was signiﬁcantly different (P , 0.05; symbol not shown) from ba-
solaterally applied ATP.
Figure 3. Summary data on anion secretion
and intracellular Ca21 (Ca21
i) in normal and cys-
tic ﬁbrosis (CF) nasal epithelia exposed to 100
mM of mucosal (A) or serosal (B) UTP. Normal
and CF values are signiﬁcantly different (*P  ,
0.05 and **P , 0.01) from each other. For baso-
lateral changes in Ca21
i, values were not signiﬁ-
cantly different (P . 0.05; symbol not shown) be-
tween normal and CF epithelia. Each bar repre-
sents the mean 6 SEM for eight independent
experiments (ﬁve different individuals).57 Paradiso et al.
ﬁnite, but small, permselectivity for HCO3
2 (Linsdell et
al., 1999), and CaCC has been reported to conduct
HCO3
2 in CFTR knockout gallbladder epithelium
(Clarke et al., 2000). Therefore, the more appropriate
designation for the secretory pattern induced by P2Y2-R
activation, in our present study, is anion secretion.
Asymmetric Responses of Ca21
i and Anion Secretion to Serosal 
and Mucosal ATP
In normal airway epithelia (Fig. 1 A), serosal ATP in-
duces an initial rapid (6–8 s) increase in Ca21
i (spike),
followed by a relaxation of Ca21
i levels to a sustained
plateau over the next 2–3 min. We have previously
shown in normal nasal monolayers that the initial spike
in Ca21
i, in response to serosal ATP, was entirely due to
an internal Ca21 release that was functionally conﬁned
to the basolateral domain of cells, whereas the sus-
tained plateau phase results from inﬂux of Ca21 solely
across the basolateral membrane of cells (Paradiso et
al., 1995). Concomitant with these changes of Ca21
i, se-
rosal ATP elicited changes in Vt, reaching peak hyper-
polarizing values more slowly (i.e., DVt in which the lu-
minal side becomes more negative with respect to the
serosal bath) than the Ca21
i peak (30–60 s), then relax-
ing to a sustained plateau level over the next 2–4 min.
As with serosal ATP additions, mucosal ATP elicited a
similar, but moderately smaller, biphasic change in Ca21
i
in normal airway epithelia (Fig. 1 A; also see Fig. 2). We
have previously demonstrated (Paradiso et al., 1995) that
the initial spike of Ca21
i in response to a mucosal ATP
challenge results from internal Ca21 release from stores
in the apical domain of cells, and the sustained plateau
results from Ca21 inﬂux solely across the apical mem-
brane of these cells. However, in contrast to the pattern
of Vt changes noted with serosal ATP, mucosally applied
ATP induced a larger hyperpolarizing change in Vt, a
more rapid rise to peak values (15–30 s), and sustained
levels that were higher (see Fig. 2) than those detected
for serosal application of the triphosphate nucleotide.
For CF nasal epithelium, ATP added to the basolateral
surface of cells elicited an identical pattern of change of
Ca21
i, as was noted with serosal application of ATP in
the normal airway epithelium (Fig. 1 B; also see Fig. 2).
However, rather than eliciting a hyperpolarization of Vt,
the serosal addition of ATP resulted in a small depolar-
ization of Vt (i.e., DVt in which the luminal side becomes
more positive with respect to the serosal bath) in CF
(Fig. 1 B). Mucosal administration of ATP resulted in a
markedly larger (Figs. 1 and 2), biphasic change of
Ca21
i in CF compared with normal nasal cells. These
changes in Ca21
i were associated with a very rapid (8–10
s) hyperpolarization of Vt, reaching higher initial (rela-
tive to normal nasal) peak values within 10–15 s, before
relaxing to sustained levels over the next 1–2 min.
Fig. 2 summarizes the dose–response relationships be-
tween Ca21
i and anion transport induced by mucosal
(Fig. 2 A) or serosal (Fig. 2 B) ATP in normal and CF hu-
man airway epithelia. Mucosal addition of ATP (Fig. 2 A)
was more efﬁcacious in eliciting both changes in Ca21
i
and anion secretion in CF as compared with normal air-
way epithelium. For both normal and CF, maximal re-
sponses of Ca21
i and anion secretion were obtained at
1025–1024 M. In both tissues, ATP was equipotent for
DCa21
i and D anion secretion: for the normal airway, the
ED50 for Ca21
i mobilization and anion transport were
1.04 3 1026 M and 1.02 3 1026 M, respectively; for CF
preparations, the ED50 for Ca21
i and anion transport
were 0.69 3 1026 M and 0.78 3 1026 M, respectively.
Several key observations in normal and CF tissues
were revealed by serosal administration of ATP (Figs. 1
and 2). First, in contrast to mucosal ATP, serosally ap-
plied ATP was equally effective in mobilizing Ca21
i in
normal and CF tissues, with the maximal efﬁcacy ob-
tained at 1025–1024 M. In terms of potencies, the ED50
for Ca21
i in normal and CF were 1.44 3 1026 M and
1.58 31026 M, respectively. These potency values of nu-
cleotide-mobilized Ca21
i were not distinguishable from
values obtained for mucosal administration of ATP de-
termined in normal and CF airway epithelia. Second, in
normal airway epithelia, the anion secretory response
to mucosal ATP was greater than after serosal ATP addi-
tion, despite the larger DCa21
i for serosal compared
with mucosal ATP administration. Finally, in stark con-
trast to normal nasal tissue, serosally applied ATP failed
to induce anion secretion in CF airway tissue.
Effects of UTP on Changes in Ca21
i and Anion Secretion in 
Airway Epithelia
Because ATP can be hydrolyzed to other agonists (e.g.,
adenosine) that modulate anion secretion via cAMP-
dependent regulation of CFTR (Lazarowski et al., 1992),
we next examined changes in Ca21
i and anion trans-
port to UTP. Note that UTP is a potent P2Y2-R agonist
(Mason et al., 1991) and its hydrolysis product, uridine,
does not activate adenosine receptors present in airway
epithelia (Lazarowski et al., 1992). Because of the lim-
ited availability of CF tissues, only a single dose of UTP
(100 mM) was tested.
As presented in Fig. 3, mucosal/serosal administra-
tion of UTP elicited the same asymmetric pattern of re-
sponses in cell Ca21 and anion secretion as ATP in nor-
mal and CF airway epithelia. Mucosal additions of UTP
(Fig. 3 A) were effective in mobilizing Ca21
i and in-
creasing anion transport in normal and CF airway prep-
arations, but both responses were again of greater mag-
nitude in CF. Serosal administration of UTP was again
effective in raising Ca21
i to the same extent in normal
and CF airways (Fig. 3 B). Like the ATP-induced anion58 Simultaneous Measurements of Ca21
i and Cl2 Transport
Figure 4. Effects of H2DIDS
and UTP applied to the mu-
cosal (A) or serosal (B) com-
partments on the transepithe-
lial potential difference (Vt)
and intracellular Ca21 (Ca21
i)
in normal and cystic ﬁbrosis
(CF) nasal monolayers. For
these protocols, monolayers
were perfused serosally with
Kreb’s bicarbonate Ringer
and mucosally with Na1-free/
low Cl2 Ringer before add-
ing H2DIDS (1.5 mM) to the
mucosal perfusate as indi-
cated in the traces. Serosal
(S) or mucosal (M) UTP (100
mM) was applied to the apical
or basolateral membrane as
shown. Each trace is repre-
sentative of four or more
independent experiments
(three different individuals).
Figure 5. Summary data on
anion secretion and intracel-
lular Ca21 (Ca21
i) in normal
and cystic ﬁbrosis (CF) nasal
epithelia pretreated with lu-
minal H2DIDS (1.5 mM) and
exposed to a single concen-
tration (100 mM) of mucosal
(A) or serosal (B) UTP. Data
are included (from Fig. 3) for
tissues not treated with
H2DIDS for comparison with
tissues treated with the disul-
fonic stilbene. Values for
H2DIDS-treated tissues and
tissues not treated with
H2DIDS are signiﬁcantly dif-
ferent (**P , 0.01) or other-
wise not different (P . 0.05;
symbol not shown) from each
other. For H2DIDS-treated tis-
sue, each bar is representative
of four or more independent
experiments (three different
individuals).59 Paradiso et al.
responses in normal airway epithelium, the anion
secretory response upon serosal UTP administration
was smaller than after mucosal addition, despite the
larger change in Ca21
i (Fig. 3). Again, in contrast to
normal nasal tissues, serosal UTP failed to evoke anion
secretion in CF tissues (Fig. 3 B).
As noted above, because of the limited availability of
tissues, only a single dose of UTP was tested on CF air-
way epithelia. However, in experiments performed in
normal airway, mucosal/serosal UTP (1029–1024 M; n 5
5 per dose; three or more individuals) was equipotent
with ATP for DCa21
i and D anion secretion. For muco-
sal addition of UTP, the ED50 for Ca21
i mobilization
and anion transport was 0.98 3 1026 M and 1.06 3
1026 M, respectively; for serosal application of UTP, the
ED50 for Ca21
i and anion transport was 1.12 3 1026 M
and 1.08 3 1026 M, respectively.
Protocols Using H2DIDS to Block the Ca21-activated
Anion Conductance
Because CFTR-mediated Cl2 secretion in normal airway
is resistant to inhibition by disulfonic stilbene deriva-
tives (e.g., DIDS), whereas Ca21-mediated Cl2 transport
is blocked by these drugs (Stutts et al., 1994), we next
examined the contribution of CFTR to UTP-induced
anion secretion when CaCC was inhibited by H2DIDS.
Representative traces shown in Fig. 4 depict the re-
sponses of Ca21
i and anion transport activities in nor-
mal and CF nasal epithelial monolayers treated ﬁrst
with mucosal H2DIDS (1.5 mM) before UTP (100 mM)
additions. In the normal human airway, H2DIDS mark-
edly inhibited anion secretion (z75%) in response to
mucosal UTP, and H2DIDS abolished anion transport
activity in the CF airway tissue exposed to mucosal UTP
(Figs. 4 A and 5). In contrast to mucosal UTP addition,
pretreatment of normal nasal tissues with H2DIDS had
no inhibitory effects on anion secretory responses to se-
rosal UTP (Figs. 4 B and 5). In CF airway epithelium,
serosal UTP elicited a depolarization in Vt in the pres-
ence of H2DIDS, similar to that detected in H2DIDS-
free experiments (Fig. 4 B). Importantly, mucosal
H2DIDS did not block changes in Ca21
i in response to
mucosal or serosal UTP in either normal or CF nasal tis-
sues (Fig. 4), suggesting that the inhibition of anion se-
cretion with mucosal UTP in both normal and CF nasal
tissues was not due to inhibition of P2Y2-R–dependent
Ca21
i signals. The data derived from these studies are
summarized and compared with the data generated in
tissues that were not pretreated with H2DIDS (Fig. 5).
Effects of ATP/UTP on Anion Transport in Ca21
i-clamped 
Airway Epithelial Cells
The residual anion secretory response in normal airway
epithelia resulting from mucosal UTP addition after
H2DIDS pretreatment suggested that triphosphate nu-
cleotides can modulate CFTR via a signal transduction
pathway that may or may not involve changes in Ca21
i.
Thus, an important aspect of this study was to evaluate
whether regulation of anion secretion by extracellular
ATP/UTP is tightly coupled to Ca21
i in normal and CF
human airway epithelia. To address this issue, two dif-
ferent maneuvers were used in an attempt to test
whether ATP/UTP-regulated Ca21
i could be dissoci-
ated from anion secretion.
As illustrated in Fig. 6, the ﬁrst approach involved
maximal elevation of Ca21
i by exposing cells to ionomy-
cin and the endoplasmic reticulum Ca21 pump blocker
thapsigargin, followed by ATP. In these studies, normal
Figure 6. Separation between intracellular Ca21 (Ca21
i) and the
transepithelial potential difference (Vt) in response to ATP in nor-
mal (A and B) and cystic ﬁbrosis (CF; C) nasal epithelia. For these
protocols, monolayers were perfused serosally with Kreb’s bicar-
bonate Ringer and mucosally with Na1-free/low Cl2 Ringer before
adding 300 nM ionomycin (Iono) and 500 nM thapsigargin (Tg)
to the mucosal perfusate as indicated in the traces. Serosal (S) or
mucosal (M) ATP (100 mM) was applied to the basolateral or api-
cal membrane as shown. Each trace is representative of four or
more independent experiments (three different individuals).60 Simultaneous Measurements of Ca21
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(Fig. 6, A and B) and CF (Fig. 6 C) nasal monolayers
were ﬁrst exposed to mucosal ionomycin (300 nM),
which, in the presence of symmetrical extracellular
Ca21 (1.3 mM), resulted in a maximal increase of Ca21
i;
subsequent addition of serosal ionomycin (300 nM; not
shown) or mucosal thapsigargin (500 nM; Fig. 6)
caused no additional change in Vt and cell Ca21. We
next tested the effects of unilaterally applied triphos-
phate nucleotides on changes of Ca21
i and Vt. In the
normal airway, serosal (Fig. 6 A) and mucosal (Fig. 6 B)
ATP (100 mM) induced an additional increase in Vt
without an apparent additional change in Ca21
i. In con-
trast to normal nasal tissues, neither serosal nor mu-
cosal administration of ATP elicited changes in Vt in CF
airway epithelium (Fig. 6 C). The summary data derived
from these protocols using ATP or UTP as the nucle-
otide agonist were analyzed sequentially, ﬁrst, for the ef-
fects of ionomycin alone on Ca21
i and anion secretion
(see Fig. 7) and, second, for the effects of mucosal and
serosal ATP/UTP on Ca21
i and anion transport (see
Fig. 8) after pretreatment with ionomycin/thapsigargin
in normal and CF airway preparations.
As shown in Fig. 7, Ca21
i increased to the same extent
in normal and CF airway epithelia in response to iono-
mycin (Fig. 7 A). However, in contrast to ionomycin-
induced changes in Ca21
i, anion secretion in response
to ionomycin was of greater magnitude in CF as com-
pared with normal nasal tissues (Fig. 7 B). The differ-
ences in ionomycin-induced changes in anion secretion
between normal and CF nasal epithelia, as reported
here, are consistent with previous reports of upregula-
tion of ionomycin-stimulated anion secretion in cultured
human CF nasal epithelium (Johnson et al., 1995).
The ATP/UTP summary data are shown in Fig. 8. Un-
der conditions in which the cell Ca21 was clamped at
high levels with ionomycin/thapsigargin pretreatment,
Figure 7. Summary data showing changes in in-
tracellular Ca21 (Ca21
i; A) and anion secretion
(B) in normal and cystic ﬁbrosis (CF) monolayers
exposed to mucosal ionomycin (300 nM). Each
bar represents mean 6 SEM for 40 or more inde-
pendent experiments (three different individu-
als). For Ca21
i, normal and CF values are not sig-
niﬁcantly different (P . 0.05; symbol not shown)
from each other; for anion secretion, normal and
CF values are signiﬁcantly different (**P , 0.01)
from each other.
Figure 8. Summary data
showing changes in anion se-
cretion and intracellular Ca21
(Ca21
i) in normal and cystic
ﬁbrosis (CF) nasal epithelia
exposed to mucosal (A) or se-
rosal (B) ATP (100 mM) or
UTP (100 mM) under high
Ca21
i conditions. Monolayers
were pretreated with 300 nM
ionomycin 1 500 nM thapsi-
gargin before ATP/UTP addi-
tions (see Fig. 6). Each bar
represents mean 6 SEM for
four or more independent
experiments (three different
individuals). Mucosal ATP/
UTP-stimulated anion trans-
port activities were signiﬁ-
cantly (**P  , 0.01) larger
than serosal ATP/UTP equiv-
alent currents. No signiﬁcant
change (P . 0.05; symbol not
shown) in Ca21
i was detected
with mucosal/serosal addi-
tion of agonists.61 Paradiso et al.
ATP and UTP were equally effective in inducing anion
secretion without affecting Ca21
i when applied to either
the mucosal (Fig. 8 A) or serosal (Fig. 8 B) compart-
ment in normal nasal monolayers. However, the anion
secretory response was of a greater magnitude to mu-
cosal additions of triphosphate nucleotides as compared
with serosal additions of the agonists. Under these same
conditions, neither ATP nor UTP applied to either
membrane (apical/basolateral) induced an anion secre-
tory or Ca21
i response in CF airway cells (Fig. 8).
In the second approach, normal and CF airway epi-
thelia were exposed to BAPTA-AM to clamp Ca21
i to
low levels. To reduce Ca21 inﬂux that would result from
P2Y2-R activation (Paradiso et al., 1995), nasal monolay-
ers were exposed to bilateral low Ca21 (300 mM) solu-
tions. As illustrated in Fig. 9, the addition of serosal
(Fig. 9 A) or mucosal (Fig. 9 B) ATP (100 mM) failed to
raise Ca21
i, but increased Vt, in normal nasal epithe-
lium. The responsiveness of preparations in the pres-
ence of BAPTA was tested by the response to the cAMP-
mediated agonist forskolin. Mucosally applied forskolin
(10 mM) evoked an additional increase in Vt in normal
airway tissue (Fig. 9, A and B). In marked contrast to
the normal nasal preparation, neither serosal nor mu-
cosal ATP, nor mucosal forskolin, elicited changes in Vt
in CF (Fig. 9 C). However, when monolayers were ex-
posed bilaterally to high extracellular Ca21 (1.3 mM)
plus mucosal ionomycin (300 nM), Ca21
i slowly in-
creased, followed by a small anion secretory response
in CF, verifying the responsiveness of the preparation.
It should be noted that BAPTA is a very effective buffer
of Ca21. To detect a change in cell Ca21 in BAPTA-
loaded cells, sufﬁcient Ca21 inﬂux must occur to over-
whelm the buffering capacity of BAPTA, thus, giving
rise to the slow increase in Ca21
i (Fig. 9 C). The small
magnitude of change in Vt shown in Fig. 9 C may be re-
lated not only to the magnitude change in Ca21
i, but
also to the rate of change of cell Ca21 (which is not a fo-
cus of our study). Data for the mucosal and serosal
ATP/UTP on changes in anion transport rates and
Ca21
i levels in BAPTA-treated normal and CF airway ep-
ithelia are summarized in Fig. 10 (A and B).
There are several relevant observations arising from
the Ca21 clamp experiments that should be of note.
First, in normal nasal monolayers, the magnitude of
the anion secretory response to apically applied ATP/
UTP was identical under experimental conditions
when cell Ca21 was clamped at high levels with ionomy-
cin/thapsigargin treatment or low levels with BAPTA
treatment (Figs. 8 and 10, respectively), strongly indi-
cating that the signaling pathway underlying triphos-
phate nucleotide stimulation of anion secretion has a
molecular component that is independent of Ca21
i,
likely via CFTR, during P2Y2-R activation. Second, in
normal airway cells, serosal ATP/UTP-stimulated anion
transport rates under both Ca21
i-clamped conditions
were smaller than those observed for mucosal additions
of ATP/UTP. These data suggest that molecular mech-
anism(s) underlying the signaling pathway for the stim-
ulation of anion transport by ATP/UTP under Ca21
i-
clamped conditions is less efﬁcient for serosal compared
with mucosal addition of these triphosphate nucle-
otides. Finally, in CF nasal monolayers, mucosal addi-
tion of ATP/UTP failed to elicit an anion secretory re-
sponse in Ca21
i-clamped cells, suggesting that CaCC is
the sole Cl2 channel mediating anion transport activity
in CF nasal epithelia.
Effects of PKC Activation and Inhibition on UTP-stimulated 
Anion Secretion in Ca21
i-clamped Normal Nasal Tissue
We have previously reported (Boucher et al., 1989) no
detectable difference in total PKC activity in normal and
Figure 9. Changes in the transepithelial potential difference
(Vt) and intracellular Ca21 (Ca21
i) activities in response to serosal
(S) or mucosal (M) ATP (100 mM) in normal (A and B) or cystic ﬁ-
brosis (CF; C) BAPTA-treated nasal epithelial preparations. Mono-
layers were initially perfused with serosal Kreb’s bicarbonate
Ringer/mucosal Na1-free/low Cl2 Ringer and low bilateral extra-
cellular Ca21 (300 mM) before the addition of ATP, as indicated in
the traces. For normal and CF nasal preparations, forskolin (Forsk;
10 mM) was added to the mucosal perfusate at the times indicated.
In CF preparations, ionomycin (Iono; 300 nM) 1 extracellular
Ca21 (1.3 mM ﬁnal concentration) was added to the mucosal bath
as shown in the trace. Each trace is representative of at least ﬁve in-
dependent experiments (four or more different individuals).62 Simultaneous Measurements of Ca21
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CF airway, despite the fact that the PKC activator PMA
had the capacity to stimulate anion transport in normal,
but not CF, nasal epithelia, via PKC-dependent phos-
phorylation of CFTR. Based on this earlier work, and
our data showing that ATP/UTP applied to either mem-
brane (apical/basolateral) of normal airway epithe-
lial cells induce anion secretion independently from
changes in Ca21
i (Figs. 8 and 10), we tested whether a
Ca21-independent PKC was a functional regulator of
CFTR-mediated anion secretion after P2Y2-R activation.
In these studies, monolayers of normal nasal epithelia
were Ca21
i-clamped by BAPTA, and the effects of PKC
activation or inhibition by PMA or chelerythrine, respec-
tively, on UTP-elicited anion secretion were examined.
As shown in Fig. 11, mucosal addition of PMA (100
nM) to normal airway epithelia caused an increase in Vt
with no change in Ca21
i (Fig. 11 A). Importantly, subse-
quent exposure of nasal cells to serosal and mucosal UTP
(100 mM) failed to cause an additional increase in Vt, de-
spite the fact that mucosal addition of forskolin (10 mM)
markedly stimulated anion transport activity (Fig. 11 A).
At the concentration used in the study, chelerythrine
chloride is a speciﬁc but broad spectrum inhibitor of
PKC isozymes (Herbert et al., 1990). Therefore, we
next examined whether this agent could block both the
UTP- and PMA-stimulated anion transport in Ca21
i-
clamped normal nasal monolayers. As shown in Fig. 11
B, pretreating nasal monolayers with chelerythrine (1
mM) completely blocked serosal and mucosal UTP-
stimulated increase in anion secretion, and markedly
inhibited both PMA- and forskolin-stimulated anion
transport. The data generated from these studies are
summarized in Fig. 11 C.
DISCUSSION
Purinoceptors Involved in Airway Epithelial Ion
Transport Regulation
Extracellular nucleotides regulate cellular processes via
interactions with cell-surface ion-gated (P2X) and G
protein–coupled (P2Y) receptors. Previous studies in
human airways (Paradiso et al., 1995) have identiﬁed a
major role for P2Y-Rs and a little role for P2X receptors
in the lumen facing (columnar) cells of the superﬁcial
epithelium of airways. Moreover, the observation that
ATP and UTP were equipotent in mediating DCa21
i
(Fig. 2 and associated text of Fig. 3) argues that the
P2Y2-R, and not P2X-Rs, mediated the nucleotide re-
sponses on both the apical and basolateral surfaces of
our airway preparations.
P2Y2 purinoceptors activate PLCb in a heterotrimeric
G protein–dependent manner (Boeynaems et al., 1998)
and increase Ca21
i through two distinct, but related
pathways. Initially, IP3 is formed from PLC-induced
breakdown of phosphatidylinositol 4,5-bisphosphate
(PIP2) and activates IP3 channel receptors in the endo-
plasmic reticulum, resulting in channel opening and
release of stored calcium into the cytoplasm. Subse-
quently, depletion of intracellular Ca21 stores activates
a pathway for Ca21 inﬂux across the plasma membrane,
Figure 10. Summary data
showing changes in anion
transport and intracellular
Ca21 (Ca21
i) activities in nor-
mal and cystic ﬁbrosis (CF)
nasal epithelium exposed to
mucosal (A) or serosal (B)
ATP (100 mM) or UTP (100
mM) in BAPTA pretreated
cells. Monolayers were per-
fused with serosal Kreb’s
bicarbonate Ringer/mucosal
Na1-free/low Cl2 Ringer and
low bilateral extracellular
Ca21 (300 mM) before triphos-
phate nucleotide addition.
Each bar represents mean 6
SEM for at least ﬁve indepen-
dent experiments (four or
more different individuals).
Mucosal ATP/UTP-stimu-
lated equivalent currents were
signiﬁcantly (**P  , 0.01)
larger than serosal ATP/UTP
transport activities. No signiﬁ-
cant change (P . 0.05; sym-
bol not shown) in Ca21
i was
detected with mucosal/sero-
sal addition of agonists.63 Paradiso et al.
which was originally termed “capacitative Ca21 entry”
or, more recently, “store-operated calcium entry” (Clap-
ham, 1995; Putney, 1986, 1990). Both phases of Ca21
mobilization can act in concert for the subsequent
modulation of multiple plasma membrane transport
processes, including the Ca21-activated Cl2 channel
(i.e., CaCC) in airway epithelia.
Besides PLC-mediated changes of Ca21
i, another con-
sequence of PLC-dependent PIP2 breakdown is the for-
mation of diacylglycerol (DAG) and its activation of PKC.
PKC activation may principally regulate human airway se-
cretion via interactions with CFTR. For example, regula-
tion of the CFTR Cl2 channel by PKC has been reported
in previous studies performed in a variety of epithelial
cell lines expressing CFTR (Dechecchi et al., 1992, 1993;
Bajnath et al., 1993; Winpenny et al., 1995; Jia et al.,
1997). Moreover, studies by Picciotto and co-workers
(Picciotto et al., 1992) showed that PKC phosphorylated
CFTR in a Ca21-independent manner, and their ﬁndings
agree with more recent studies by Liedtke and Cole
(1998), who reported that Ca21-independent PKC-« reg-
ulates cAMP-dependent stimulation of the CFTR Cl2
channel in Calu-3 cells, an airway epithelial cell line.
Compelling evidence has been reported that the reg-
ulation of Cl2 secretion in normal airway epithelia may
reﬂect more than a simple change in Ca21
i mediated by
extracellular triphosphate nucleotides. For example,
Hwang et al. (1996) reported that triphosphate nucle-
otides activated multiple types of Ca21-sensitive and
Ca21-insensitive Cl2 conductances in rat tracheal epi-
thelial cells. A dissociation between the regulation of
Cl2 conductance and Ca21
i activity by extracellular ATP
was also seen in voltage clamp studies in CFT1 cells by
Stutts and co-workers (Stutts et al., 1994), suggesting
multiple modes of regulation of Cl2 transport rates by
extracellular ATP. However, these earlier studies used
separate experimental systems for monitoring ion trans-
port activities and for measurements of Ca21
i (either di-
rectly or indirectly) in airway epithelial preparations.
To better quantitate the role of intracellular Ca21 in
modulating anion transport activity in polarized tissues,
we used a unique experimental technique that allowed
us to measure simultaneous changes of Ca21
i and anion
secretion induced by P2Y2-R activation in polarized nor-
mal and CF human airway epithelia (Fig. 1). Because
the results of these studies were extensive and complex,
we have elected to present them with respect to nucle-
otide addition selectively at each barrier, starting with
the simplest system (i.e., CF) in which CFTR function is
absent. We then present data in the more complex nor-
mal airway epithelium.
Apical P2Y2-R Regulation of Anion Secretion in CF
Airway Epithelia
The large anion secretory responses of CF tissues to
mucosal ATP/UTP (Figs. 2 and 3) are consistent with
previous results seen in CF airway epithelia (Clarke and
Boucher, 1992). The Cl2 secretory response in cultured
CF airway epithelia in response to ionomycin or ATP
was shown directly by microelectrode studies to arise
principally from activation of a Cl2 conductance (Figs.
2 and 7) in the apical membrane (Willumsen and
Boucher, 1989; Clarke and Boucher, 1992).
A comprehensive set of protocols was developed to
directly test the linkage between apical (versus basolat-
eral) nucleotide–induced Ca21
i and anion secretion.
Contrasting maneuvers were used to clamp Ca21
i at dif-
ferent levels in CF nasal tissues. The ﬁrst approach in-
volved maximally elevating Ca21
i by the addition of ion-
Figure 11. Effect of PMA and chelerythrine chloride on UTP-
stimulated anion secretion in intracellular Ca21 (Ca21
i)-clamped
normal nasal monolayers. In the absence (A) or presence (B) of
chelerythrine (1 mM), monolayers were perfused serosally with
Kreb’s bicarbonate Ringer and mucosally with Na1-free/low Cl2
Ringer before adding serosal (S) or mucosal (M) PMA (100 nM),
UTP (100 mM), or forskolin (F; 10 mM) as indicated. C shows sum-
mary data generated from four or more independent experiments
(three different individuals). Chelerythrine signiﬁcantly (**P ,
0.01) blocked PMA and UTP-induced anion transport activities.64 Simultaneous Measurements of Ca21
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omycin, followed by thapsigargin. CF nasal tissue pre-
treated with these agents exhibited no additional
change in Ca21
i in response to apically or basolaterally
applied ATP/UTP, and ATP/UTP failed to increase the
anion transport rate (Figs. 6 and 8). In the second ap-
proach, nasal monolayers were pretreated with BAPTA-
AM to clamp Ca21
i to low levels. These experiments re-
vealed that the addition of mucosal ATP/UTP to
BAPTA-treated CF cells caused no change in Ca21
i, and
again failed to increase anion secretion in CF epithe-
lium (Figs. 9 and 10). The data showing that Ca21
i-
clamped CF epithelium failed to elicit an anion secre-
tory response to mucosal ATP/UTP, coupled with data
that showed that anion transport induced by mucosal
UTP in CF epithelium was completely inhibited by
H2DIDS (Figs. 4 and 5), argue that anion secretion in
CF epithelia in response to ATP/UTP is mediated ex-
clusively via Ca21
i regulation of CaCC.
A key observation of this study was the markedly
larger Ca21
i response of CF as compared with normal
tissues to mucosal ATP/UTP (Figs. 2 and 3), raising the
possibility that regulation of Ca21
i metabolism is differ-
ent in CF. Based on our functional data alone, it is not
apparent how mucosal ATP/UTP activated a larger
Ca21
i signal in CF compared with normal cells. However,
in human proximal airway epithelia, we have recently
performed preliminary studies using immunoﬂuores-
cent confocal imaging of the endoplasmic reticulum
(the site of IP3-releasable Ca21 stores) markers, calreti-
culin, and IP3 receptors, which show that endoplasmic
reticulum Ca21 stores are preferentially distributed to
the apical domain, and that CF cells exhibit a greater ex-
pression of apical ER Ca21 stores (Ribeiro et al., 1999).
Basolateral P2Y2-R Regulation of Anion Secretion in CF 
Airway Epithelia
A central observation of this study was that basolateral
activation of P2Y2-R with ATP or UTP raised Ca21
i to the
same extent in both CF and normal airway epithelia,
but failed to induce anion secretion in CF. This observa-
tion strongly indicates that Ca21, mobilized by activa-
tion of the basolateral P2Y2-R, is functionally conﬁned
to that barrier, i.e., the Ca21
i released from basolateral
stores cannot activate apical Ca21-sensitive Cl2 chan-
nels. Our data in normal tissues imply that this compart-
mentalized release/regulation of Ca21
i in response to
basolateral ATP/UTP is also a feature of normal airway
epithelia (Figs. 4 and 5). Previous microelectrode stud-
ies demonstrated that apical nucleotide administration,
unlike basolateral nucleotide administration, did not
activate basolateral Ca21-activated K1 channels (Clarke
and Boucher, 1992), suggesting that this compartmen-
talization is symmetric. The mechanism for compart-
mentalization of Ca21 signaling in airway epithelia is un-
known, but it may involve the actions of mitochondria
acting as a “Ca21 fence” (Tinel et al., 1999) and/or Ca21
binding proteins (Nomiya et al., 1998).
Apical Membrane P2Y2-R Regulation of Anion Secretion in 
Normal Airway Epithelia
For apical P2Y2-R–regulated anion secretion in normal
airway tissue, we propose that two distinct Cl2 channels
(e.g., CaCC and CFTR) mediate anion efﬂux across the
apical membrane, and that the linkage coupling activa-
tion of apical P2Y2-R to the induction of anion trans-
port involves both Ca21
i-regulated CaCC and Ca21-inde-
pendent PKC-regulated CFTR. We make these specula-
tions based on the following observations. In normal
human airway epithelial cells, the majority of anion se-
cretion mediated by apical P2Y2-Rs reﬂects Ca21
i-regu-
lated activation of CaCC. In support of this notion, an-
ion transport activity was substantially blocked (z75%)
by luminal H2DIDS in response to mucosal UTP (Figs.
4 and 5). Additional support for CaCC as the major ef-
ﬂux pathway during ATP/UTP-regulated anion secre-
tion came from experiments that showed markedly re-
duced anion transport activity in Ca21
i-clamped normal
airway monolayers in response to apically applied ATP/
UTP (Figs. 8 and 10).
However, the observation that mucosally applied
ATP/UTP-stimulated anion secretion was reduced, but
not abolished, in normal airway epithelium by H2DIDS
or Ca21
i-clamping agents indicates that apical P2Y2-R
activation modulates multiple Cl2 channels via Ca21-
dependent (i.e., CaCC) and Ca21-independent signal
transduction pathways. We propose that the Ca21-inde-
pendent signaling pathway linking apical P2Y2-R activa-
tion to anion secretion reﬂects Ca21-independent PKC
regulation of CFTR-mediated anion secretion for sev-
eral reasons. First, as noted above, activation of the api-
cal P2Y2-Rs by ATP/UTP increased anion secretory ac-
tivity in a Ca21-independent manner (Figs. 8 and 10).
Second, the PMA-stimulated anion secretion abolished
UTP-regulated anion secretion (Fig. 11) in Ca21
i-
clamped monolayers, suggesting that the PMA- and
UTP-regulated signaling pathways occur via the same
cellular mechanism (i.e., Ca21-independent PKC). Fi-
nally, PKC inhibition by chelerythrine completely abol-
ished apically applied UTP-regulated anion secretion
under Ca21
i-clamped conditions (Fig. 11), which is con-
sistent with the notion that a Ca21-independent PKC is
the intracellular second messenger relevant to CFTR-
mediated anion secretion in normal airway epithelia.
Basolateral Membrane P2Y2-R Activation of Anion Transport 
in Normal Airway Epithelia
For basolateral P2Y2-R–regulated secretion, we propose
that (1) only a single Cl2 channel (i.e., CFTR) mediates
anion efﬂux across the apical membrane, and (2) that
the linkage between P2Y2-R activation and CFTR in-65 Paradiso et al.
volves regulation via PKC rather than Ca21
i. Several ob-
servations support these hypotheses. In normal nasal
epithelium, the addition of basolateral ATP/UTP con-
sistently increased the anion secretory rate, but no
changes in anion secretion were noted in CF. These
data clearly point to the requirement for functional
CFTR to mediate anion secretion after basolateral addi-
tion of ATP/UTP. The identiﬁcation of CFTR and not
CaCC as the apical membrane anion efﬂux pathway
during basolateral P2Y2-R activation is further sup-
ported by data that show that mucosal H2DIDS failed to
block anion secretion in normal nasal tissues induced
by serosal UTP, but abolished anion secretion in re-
sponse to mucosal UTP in CF (Figs. 4 and 5).
The notion that the apical membrane CFTR-medi-
ated anion conductance is regulated by a Ca21-inde-
pendent PKC is based on several interrelated observa-
tions derived from the Ca21
i-clamped studies. First, as
noted above, activation of the basolateral P2Y2-Rs by
ATP/UTP increased anion transport activity in a Ca21-
independent manner (Figs. 8 and 10). Second, no ad-
ditivity was observed between the PMA-stimulated an-
ion secretion and basolateral UTP-regulated anion
transport (Fig. 11) in Ca21
i-clamped monolayers, again
suggesting that the PMA- and UTP-regulated signaling
pathways occur via the same cellular mechanism, i.e.,
Ca21-independent PKC. Finally, PKC inhibition by chel-
erythrine completely abolished serosally applied UTP-
regulated anion secretion under Ca21
i clamp condi-
tions (Fig. 11), which is again consistent with the no-
tion that a Ca21-independent PKC is the intracellular
messenger relevant to CFTR-mediated anion secretion
in normal human airway epithelia.
Ion Transport Model
In summary, the model depicted in Fig. 12 shows that,
in normal epithelium, basolateral P2Y2-R activation
couples to apical anion secretion through two related
pathways. First, the Ca21
i signal resulting from PLC-
generated IP3 activates Ca21-dependent K1 channels on
the basolateral membrane, promoting membrane hy-
perpolarization and generation of a loop current re-
sponsible for CFTR-mediated anion secretion. Second,
PLC-generated DAG activates a Ca21-independent PKC
which, directly or indirectly, activates CFTR-dependent
anion transport. In this model, PKC (or one of its tar-
gets) translocates from the basolateral to the apical do-
main where it can modulate CFTR function, whereas
the Ca21
i signal generated by basolateral nucleotide ap-
plication is restricted to the basolateral compartment.
In contrast, apical P2Y2-R activation in normal epithe-
lium increases anion secretion as a result of Ca21-depen-
dent activation of CaCC as well as CFTR regulation by a
Ca21-independent PKC.
In CF epithelium, although basolateral P2Y2-R activa-
tion stimulates PLC to the same extent as in normal ep-
Figure 12. Model for basolat-
eral and apical P2Y2 receptor
(P2Y2-R) activation of anion se-
cretion in normal and cystic ﬁ-
brosis (CF) human airway epi-
thelia. ATP; UTP; P2Y2-R (P2Y2
purinergic receptor); Gq (het-
erotrimeric GTP-binding pro-
tein); PLC (phospholipase C);
IP3 (inositol 1,4,5-triphos-
phate); Ca21
i (intracellular
Ca21); DAG (diacylglycerol);
PKC; CFTR (cystic ﬁbrosis
transmembrane conductance
regulator); and CaCC (Ca21-
activated Cl2 channel).66 Simultaneous Measurements of Ca21
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ithelium, Ca21-activated K1 channel–dependent mem-
brane hyperpolarization and DAG-activated PKC do
not generate anion secretion because of the lack of
functional CFTR expression at the apical barrier. How-
ever, apical P2Y2-R activation in CF results in a large
Ca21
i mobilization, accounting for the large CaCC-
mediated anion secretion compared with normal epi-
thelium. Similar to basolateral P2Y2-R–dependent sig-
nal transduction, apical receptor stimulation–activated
PKC does not couple to anion transport in CF because
of the absence of functional CFTR.
Role of Apical and Basolateral P2Y2-R in Airway
Epithelial Function
The protocols using Na1-free/low Cl2 luminal solu-
tions were designed to allow us to use anion secretion
as a sensitive read-out of P2Y2-R–mediated signal trans-
duction at apical and basolateral barriers. This strategy
allowed us to discover that airway epithelia appear to
be able to functionally conﬁne Ca21-regulated signal-
ing to the barrier ipsilateral to receptor stimulation,
whereas other pathways (e.g., PKC) are not. Thus, both
normal and CF airways may be able to respond selec-
tively to nucleotide (and perhaps other agonists) stimu-
lation at the apical or basolateral barriers.
These data also could have implications for regula-
tion of net transepithelial ion transport rates. Although
not explored in this study, extracellular nucleotides in-
hibit epithelial Na1 channel (Devor and Pilewski,
1999) and limit Na1 absorption in airway epithelia. Un-
der these conditions, driving forces for Cl2 secretion
across epithelia exist. In normal airways, anion trans-
port resulting from P2Y2-R stimulation at either barrier,
via regulation of CFTR and/or CaCC, could play a vital
role in the composition, pH (e.g., secreted HCO3
2),
and depth of airway surface liquids, facilitating the
maintenance of the mucociliary clearance mechanism
and, thus, airway homeostasis. On the other hand, in
CF airways, there is a predicted failure to respond to
nucleotides released in the vicinity of the basolateral
barrier, e.g., from inﬂammatory cells or autocrine re-
lease. The failure to respond could limit the ability of
the CF epithelium to respond to submucosal stresses.
Conversely, although CaCC, under resting circum-
stances, appears to be inactive, the large Ca21-releas-
able stores and apparent upregulation of CaCC make
activation of the pathway to initiate anion secretion to
restore volume on airway surfaces by luminal nucle-
otides an attractive therapeutic strategy.
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